D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 47 Citations 9,154 124 World Ranking 2435 National Ranking 1008

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Cancer

Andrew H. Limper mostly deals with Pneumocystis carinii, Microbiology, Lung, Respiratory disease and Immunology. The study incorporates disciplines such as Cell culture, Phagocytosis, Glycoprotein, Macrophage and Fungal protein in addition to Pneumocystis carinii. His research in Microbiology tackles topics such as Receptor which are related to areas like Inflammation, Secretion and Pulmonary alveolus.

His Lung study incorporates themes from Chemotherapy induced and Corticosteroid therapy. His Respiratory disease research is under the purview of Internal medicine. His work on Pneumovirus, Mononegavirales and Pneumovirinae as part of general Immunology study is frequently linked to AIDS-Related Opportunistic Infections, bridging the gap between disciplines.

His most cited work include:

  • Medical progress: Pneumocystis pneumonia (645 citations)
  • Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis (527 citations)
  • Pneumocystis carinii Pneumonia in Patients Without Acquired Immunodeficiency Syndrome: Associated Illnesses and Prior Corticosteroid Therapy (449 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Pneumocystis carinii, Immunology, Microbiology, Internal medicine and Lung. His work focuses on many connections between Pneumocystis carinii and other disciplines, such as Cell biology, that overlap with his field of interest in Secretion. His Immunology research is multidisciplinary, relying on both Pneumocystis pneumonia and Pneumonia.

His Microbiology research focuses on Tumor necrosis factor alpha and how it connects with Proinflammatory cytokine. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Surgery and Oncology. His Lung course of study focuses on Pathology and Idiopathic pulmonary fibrosis.

He most often published in these fields:

  • Pneumocystis carinii (27.98%)
  • Immunology (23.21%)
  • Microbiology (19.35%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (17.56%)
  • Immunology (23.21%)
  • Pneumocystis pneumonia (11.90%)

In recent papers he was focusing on the following fields of study:

Andrew H. Limper mainly focuses on Internal medicine, Immunology, Pneumocystis pneumonia, Lung and Pulmonary fibrosis. His work is dedicated to discovering how Internal medicine, Gastroenterology are connected with Polymerase chain reaction and other disciplines. Many of his studies on Immunology involve topics that are commonly interrelated, such as Pneumonia.

He has researched Pneumocystis pneumonia in several fields, including Incidence, Pneumocystis jirovecii, Retrospective cohort study and Respiratory failure. In the field of Lung, his study on Idiopathic pulmonary fibrosis overlaps with subjects such as Viral pneumonia. Andrew H. Limper works mostly in the field of Innate immune system, limiting it down to topics relating to Pneumocystis carinii and, in certain cases, Cell biology.

Between 2017 and 2021, his most popular works were:

  • Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline (45 citations)
  • Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis An Official American Thoracic Society Research Statement (32 citations)
  • Early Corticosteroids for Pneumocystis Pneumonia in Adults Without HIV Are Not Associated With Better Outcome (30 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Cancer

Andrew H. Limper mostly deals with Internal medicine, Immunology, Lung, Respiratory system and Cancer research. His Immunology research incorporates elements of Oxidative stress and Pneumonia. His study looks at the intersection of Pneumonia and topics like Receiver operating characteristic with Bronchoalveolar lavage.

His study looks at the relationship between Lung and fields such as Inflammation, as well as how they intersect with chemical problems. His work deals with themes such as Pneumocystis pneumonia, Mechanical ventilation, Retrospective cohort study and Respiratory failure, which intersect with Respiratory system. His Cancer research research integrates issues from Transcriptome, Lung cancer and COPD.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Medical progress: Pneumocystis pneumonia

Charles F. Thomas;Andrew H. Limper.
The New England Journal of Medicine (2004)

1014 Citations

Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis

Craig E. Daniels;Mark C. Wilkes;Maryanne Edens;Ted J. Kottom.
Journal of Clinical Investigation (2004)

816 Citations

Pneumocystis carinii Pneumonia in Patients Without Acquired Immunodeficiency Syndrome: Associated Illnesses and Prior Corticosteroid Therapy

Steven H. Yale;Andrew H. Limper.
Mayo Clinic Proceedings (1996)

694 Citations

An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients

Andrew H. Limper;Kenneth S. Knox;George A. Sarosi;Neil M. Ampel.
American Journal of Respiratory and Critical Care Medicine (2011)

617 Citations

Pneumocystis carinii Pneumonia: Differences in Lung Parasite Number and Inflammation in Patients with and without AIDS

Andrew H. Limper;Kenneth P. Offord;Thomas F. Smith;William J. Martin.
The American review of respiratory disease (1989)

573 Citations

Pulmonary Langerhans'-cell histiocytosis.

Robert Vassallo;Jay H. Ryu;Thomas V. Colby;Thomas Hartman.
The New England Journal of Medicine (2000)

561 Citations

Tracheobronchial Foreign Bodies in Adults

Andrew H. Limper;Udaya B. S. Prakash.
Annals of Internal Medicine (1990)

546 Citations

Stretch induces cytokine release by alveolar epithelial cells in vitro.

Nicholas E. Vlahakis;Mark A. Schroeder;Andrew H. Limper;Rolf D. Hubmayr.
American Journal of Physiology-lung Cellular and Molecular Physiology (1999)

530 Citations

Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults.

Robert Vassallo;Jay H. Ryu;Darrell R. Schroeder;Paul A. Decker.
The New England Journal of Medicine (2002)

478 Citations

Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results.

Craig E. Daniels;Joseph A. Lasky;Andrew H. Limper;Kathleen Mieras.
American Journal of Respiratory and Critical Care Medicine (2010)

456 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Andrew H. Limper

Jay H. Ryu

Jay H. Ryu

Mayo Clinic

Publications: 47

Melanie T. Cushion

Melanie T. Cushion

University of Cincinnati Medical Center

Publications: 46

Eduardo Dei-Cas

Eduardo Dei-Cas

Institut Pasteur

Publications: 40

Luca Richeldi

Luca Richeldi

Catholic University of the Sacred Heart

Publications: 39

Fernando J. Martinez

Fernando J. Martinez

Cornell University

Publications: 34

Jesse Roman

Jesse Roman

Thomas Jefferson University

Publications: 31

David A. Lynch

David A. Lynch

Children's Hospital of Philadelphia

Publications: 30

Jay K. Kolls

Jay K. Kolls

Tulane University

Publications: 30

Peter D. Walzer

Peter D. Walzer

University of Cincinnati

Publications: 30

Joseph A. Kovacs

Joseph A. Kovacs

National Institutes of Health

Publications: 29

Vincent Cottin

Vincent Cottin

Claude Bernard University Lyon 1

Publications: 29

Kevin K. Brown

Kevin K. Brown

National Jewish Health

Publications: 28

Robert P. Baughman

Robert P. Baughman

University of Cincinnati

Publications: 27

Gordon D. Brown

Gordon D. Brown

University of Exeter

Publications: 26

John Varga

John Varga

University of Michigan–Ann Arbor

Publications: 24

Stéphane Bretagne

Stéphane Bretagne

Université Paris Cité

Publications: 22

Trending Scientists

Howard A. Levine

Howard A. Levine

Iowa State University

Vladimir Spokoiny

Vladimir Spokoiny

Weierstrass Institute for Applied Analysis and Stochastics

Mitsuharu Morisawa

Mitsuharu Morisawa

National Institute of Advanced Industrial Science and Technology

Dieter Richter

Dieter Richter

Forschungszentrum Jülich

Kyung Byung Yoon

Kyung Byung Yoon

Sogang University

Fadi F. Hamdan

Fadi F. Hamdan

University of Montreal

Hans Eiberg

Hans Eiberg

University of Copenhagen

Luke P. Shoo

Luke P. Shoo

University of Queensland

Diane K. Stoecker

Diane K. Stoecker

University of Maryland Center For Environmental Sciences

Geert Berx

Geert Berx

Ghent University

Frederik J Hilgen

Frederik J Hilgen

Utrecht University

Slobodan B. Marković

Slobodan B. Marković

University of Novi Sad

Daehee Kang

Daehee Kang

Seoul National University

Wai Fong Chua

Wai Fong Chua

University of Sydney

Hunter G. Hoffman

Hunter G. Hoffman

University of Washington

Sheilagh Ogilvie

Sheilagh Ogilvie

University of Oxford

Something went wrong. Please try again later.